These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 21270966)

  • 21. Intramuscular versus intravenous anti-D for preventing Rhesus alloimmunization during pregnancy.
    Okwundu CI; Afolabi BB
    Cochrane Database Syst Rev; 2013 Jan; (1):CD007885. PubMed ID: 23440818
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Prevention of fetomaternal rhesus-D allo-immunization. Practical aspects].
    Cortey A; Brossard Y
    J Gynecol Obstet Biol Reprod (Paris); 2006 Feb; 35(1 Suppl):1S123-1S130. PubMed ID: 16495838
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anti-D administration in pregnancy for preventing Rhesus alloimmunisation.
    McBain RD; Crowther CA; Middleton P
    Cochrane Database Syst Rev; 2015 Sep; 2015(9):CD000020. PubMed ID: 26334436
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunological principle of development of red blood cell alloimmunization in pregnancy, hemolytic disease of the fetus and prevention of RhD alloimmunization in RhD negative women.
    Roubalová L; Lubušký M
    Ceska Gynekol; 2020; 85(6):408-416. PubMed ID: 33711901
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rhesus D alloimmunization in pregnancy from 1996 to 2015 in Iceland: a nation-wide population study prior to routine antenatal anti-D prophylaxis.
    Gudlaugsson B; Hjartardottir H; Svansdottir G; Gudmundsdottir G; Kjartansson S; Jonsson T; Gudmundsson S; Halldorsdottir AM
    Transfusion; 2020 Jan; 60(1):175-183. PubMed ID: 31850521
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The risk assessment study for hemolytic disease of the fetus and newborn in a University Hospital in Turkey.
    Altuntas N; Yenicesu I; Himmetoglu O; Kulali F; Kazanci E; Unal S; Aktas S; Hirfanoglu I; Onal E; Turkyilmaz C; Ergenekon E; Koc E; Atalay Y
    Transfus Apher Sci; 2013 Jun; 48(3):377-80. PubMed ID: 23619329
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Gel agglutination test--a new test system for semiquantitative detection of feto-maternal transfusion in Rhesus incompatibility].
    David M; Stelzer A; Wittmann G; Dudenhausen JW; Salama A
    Z Geburtshilfe Neonatol; 1999; 203(6):241-5. PubMed ID: 10612196
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of Kleihauer test in Rhesus negative pregnancy.
    Mahboob U; Mazhar SB
    J Coll Physicians Surg Pak; 2006 Feb; 16(2):120-3. PubMed ID: 16499805
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An increased risk for non allo-immunization related intrauterine fetal death in RhD-negative patients.
    Ben-David G; Sheiner E; Levy A; Erez O; Mazor M
    J Matern Fetal Neonatal Med; 2008 Apr; 21(4):255-9. PubMed ID: 18330822
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Feto - maternal haemorrhage in parturients: Incidence and its determinants.
    Adeniji AO; Mabayoje VO; Raji AA; Muhibi MA; Tijani AA; Adeyemi AS
    J Obstet Gynaecol; 2008 Jan; 28(1):60-3. PubMed ID: 18259901
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Consequences of being Rhesus D immunized during pregnancy and how to optimize new prevention strategies.
    Tiblad E; Westgren M; Pasupathy D; Karlsson A; Wikman AT
    Acta Obstet Gynecol Scand; 2013 Sep; 92(9):1079-85. PubMed ID: 23750781
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Prevention of Rh D alloimmunization in the first trimester of the pregnancy: French College of Obstetricians and Gynecologists guidelines for clinical practice].
    Vigoureux S; Maurice P; Sibiude J; Garabedian C; Sananès N
    Gynecol Obstet Fertil Senol; 2024; 52(7-8):446-453. PubMed ID: 38417789
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevalence of Rhesus C and D Alloantibodies among Rhesus-Negative Women of Child Bearing Age at a Tertiary Hospital in South-West Nigeria.
    Otomewo L; John-Olabode S; Okunade K; Olorunfemi G; Ajie I
    Niger J Clin Pract; 2020 Dec; 23(12):1759-1766. PubMed ID: 33355832
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Direct maternal morbidity and the risk of pregnancy-related deaths, stillbirths, and neonatal deaths in South Asia and sub-Saharan Africa: A population-based prospective cohort study in 8 countries.
    Aftab F; Ahmed I; Ahmed S; Ali SM; Amenga-Etego S; Ariff S; Bahl R; Baqui AH; Begum N; Bhutta ZA; Biemba G; Cousens S; Das V; Deb S; Dhingra U; Dutta A; Edmond K; Esamai F; Ghosh AK; Gisore P; Grogan C; Hamer DH; Herlihy J; Hurt L; Ilyas M; Jehan F; Juma MH; Kalonji M; Khanam R; Kirkwood BR; Kumar A; Kumar A; Kumar V; Manu A; Marete I; Mehmood U; Minckas N; Mishra S; Mitra DK; Moin MI; Muhammad K; Newton S; Ngaima S; Nguwo A; Nisar MI; Otomba J; Quaiyum MA; Sarrassat S; Sazawal S; Semrau KE; Shannon C; Singh VP; Soofi S; Soremekun S; Suleiman AM; Sunday V; Dilip TR; Tshefu A; Wasan Y; Yeboah-Antwi K; Yoshida S; Zaidi AK;
    PLoS Med; 2021 Jun; 18(6):e1003644. PubMed ID: 34181649
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Possibility to identify fetomaternal haemorrhage].
    Studnicková M; L'ubuský M; Ordeltová M; Procházka M
    Ceska Gynekol; 2010 Oct; 75(5):443-6. PubMed ID: 21374922
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Prevention of Rh (D) alloimmunization in Rh (D) negative women in pregnancy and after birth of Rh (D) positive infant].
    L'ubuský M; Procházka M; Krejcová L; Vetr M; Santavý J; Kudela M
    Ceska Gynekol; 2006 May; 71(3):173-9. PubMed ID: 16768042
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Standardization of the quantitative flow cytometric test with anti-D antibodies for fetomaternal hemorrhage in RhD negative women].
    Spychalska J; Uhrynowska M; Pyl H; Klimczak-Jajor E; Kopeć I; Peciakowska M; Gutowska R; Gawlak M; Słomska S; Dąbkowska S; Szczecina R; Dębska M; Brojer E
    Ginekol Pol; 2015 Jul; 86(7):486-93. PubMed ID: 26376524
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Obstetric management in Rh alloimmunizated pregnancy.
    Cacciatore A; Rapiti S; Carrara S; Cavaliere A; Ermito S; Dinatale A; Imbruglia L; Recupero S; La Galia T; Pappalardo EM; Accardi MC
    J Prenat Med; 2009 Apr; 3(2):25-7. PubMed ID: 22439037
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Appropriate provision of anti-D prophylaxis to RhD negative pregnant women: a scoping review.
    Fyfe TM; Ritchey MJ; Taruc C; Crompton D; Galliford B; Perrin R
    BMC Pregnancy Childbirth; 2014 Dec; 14():411. PubMed ID: 25491600
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.